相关实验视频
Updated: Jul 4, 2025

10:24
Quantitation of Endothelial Cell Adhesiveness In Vitro
Published on: June 18, 2015
11.5K
迪恩诺杰斯特不会增加粘附分子,MCP-1和人类内皮细胞中单细胞粘附的基因表达
Nanami Tahara1, Fumitake Ito1, Mari Kawamata1
1Department of Obstetrics and Gynecology, Graduate School of Medical Science, Kyoto, Japan Prefectural University of Medicine, Kyoto, Japan.
概括
迪恩诺杰斯特 (DNG) 不会增加单细胞对内皮细胞的粘附,不同于美德基酸 (MPA). 这表明DNG是激素替代疗法的更安全替代品,可能降低动脉样硬化风险.
科学领域:
- 内分泌学 在内分泌学.
- 心血管研究研究心血管研究
- 细胞生物学 细胞生物学
背景情况:
- 梅德罗西孕酸 (MPA) 与激素替代疗法 (HRT) 中动脉样硬化风险增加有关.
- 单细胞对内皮细胞的粘附是动脉样硬化的关键早期事件.
- 单细胞化学吸引蛋白-1 (MCP-1) 是这种粘附的关键媒介.
研究的目的:
- 为了评估dienogest (DNG) 作为在HRT中替代MPA的孕激素.
- 研究DNG对人类带静脉内皮细胞 (HUVECs) 中单细胞粘附和细胞因子表达的影响.
主要方法:
- 用DNG,天然孕激素或MPA治疗HUVEC,然后进行IL-1β刺激.
- 实时PCR用于测量粘附分子 (E-selectin,ICAM-1) 和细胞因子 (MCP-1,IL-6) 的mRNA表达.
- 一个流室系统评估了单细胞 (U937细胞) 粘附于HUVECs.
主要成果:
- 在HUVEC中,DNG没有改变E-选择素,ICAM-1,MCP-1或IL-6的表达.
- MPA显著增加了单细胞对HUVECs的附着性 (p < 0.05).
- 在流室系统中,DNG并没有增加单细胞粘附.
结论:
- 迪恩诺杰斯特 (DNG) 不会影响内皮细胞激活或单细胞粘附的关键标志物.
- 与MPA不同,DNG不促进单细胞粘附,这表明动脉样硬化风险可能较低.
- DNG值得考虑作为激素替代疗法的更安全的替代孕激素.
相关概念视频
Intracellular Signaling Affects Focal Adhesions
2.7K
Integrins act both as extracellular input receivers and as intracellular processing activators. As their name suggests, integrins are entirely integrated into the membrane structure. Their hydrophobic membrane-spanning regions interact with the phospholipid bilayer's hydrophobic region. These membrane receptors provide extracellular attachment sites for effectors like hormones and growth factors. They activate intracellular response cascades when their effectors are bound and active.
Some...
Some...
2.7K
Immunoglobulin-like Cell Adhesion Molecules
3.3K
Immunoglobulin-like cell adhesion molecules or Ig-CAMs are a versatile group of cell surface glycoproteins belonging to the immunoglobulin protein superfamily. Ig-CAMs possess the characteristic immunoglobulin protein domains and other domains such as the fibronectin type III domain. The Ig domains are glycosylated to varying degrees in different Ig-CAMs.
Ig-CAMs exhibit either homophilic binding (to other Ig-CAMs) or heterophilic binding (to other ligands such as integrins). While most Ig-CAMs...
Ig-CAMs exhibit either homophilic binding (to other Ig-CAMs) or heterophilic binding (to other ligands such as integrins). While most Ig-CAMs...
3.3K

